- Dear UT Health San Antonio faculty and staff: I am pleased to announce that after a competitive national search, Michael Charlton, PhD, has been selected as the new vice president for facilities and capital planning. He officially starts in the role June 1. This new position is responsible for the strategic planning and management of all […]
- An “artificial enamel” ingredient in toothpaste has been shown to help restore enamel in teeth, more effectively relieving sensitivity than fluoride while fighting cavities, according to an internationally published study led by a UT Health San Antonio School of Dentistry professor and researcher. The ingredient, a synthetic version of the natural mineral hydroxyapatite that […]
- Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, May 30, 2023 – An “artificial enamel” ingredient in toothpaste has been shown to help restore enamel in teeth, more effectively relieving sensitivity than fluoride while fighting cavities, according to an internationally published study led by a UT Health San Antonio School of Dentistry professor and researcher. The […]
- Read the full story on San Antonio Woman here. Endometriosis is a condition that many women suffer from; it is when the endometrial tissue that normally lines the uterus starts to grow in other places. It can cause severe pain in the pelvic region and make it difficult to become pregnant.
- The Max and Minnie Tomerlin Voelcker Fund is awarding $1.8 million to UT Health San Antonio to support research projects conducted by promising early career researchers.
- Monica Verduzco-Gutierrez, MD, professor and chair, Rehabilitation Medicine, was quoted in this article. Read More
- Each year, U.S. and Canadian academic health centers are invited to nominate faculty for this highly competitive program. UT Health San Antonio has a total of 13 faculty members who have successfully completed this prestigious fellowship program.
- Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and […]
- From social media to ads featuring an earworm jingle, it’s hard to escape hearing about Ozempic. Hailed for its game-changing effect on diabetes and obesity, semaglutide, the generic medication sold under the brand name Ozempic, is now being studied for its effectiveness on another deadly disease — Alzheimer’s. The Glenn Biggs Institute for Alzheimer’s and […]
- Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older Contact: Will Sansom, UT Health Science Center, 210-567-2579, sansom@uthscsa.edu University Health communications, 210-358-2335 SAN ANTONIO (May 25, 2023) — While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the […]
